First eStandards conference Panel of the European SDO Platformchronaki
Introduction to panel where Standards Developing Organization and National Competence Centers discuss the scope of the European SDO platform reflecting on earlier presentations.
Healthcare: Leadership, Integration, Platforms; CCIO experiences in the NHSTony Shannon
Presentation to HISI 2015 on experiences as a CCIO.
Issues covered:
Healthcare under pressure
Need for medical leadership
Integration of care around the patient
Advent of open platform in healthcare
Changes ahead. Progress optional
Emergency Medicine Leaders: Technology for Quality & Performance: What Leader...Tony Shannon
Brief: Technological Solutions to Achieving Quality & Performance: What Leaders Need to Know
Exploration of;
Healthcare under Pressure
Need to work Smarter>Harder
Role of Medical Leadership (eg CCIO)
Complex Systems (eg EM) .. look for patterns
People Process + Tech = key Change Pattern
State of Healthcare IT market
EDIS improvement/procurement options
Case for open platform in Health IT and EM
Medical Leadership: Complex Systems: Open PlatformsTony Shannon
Workshop at the RCPI St Lukes Symposium on themes of;
21st Century Healthcare
Need for Medical Leadership
The Challenge of Complex Systems
The Promise of Open Platforms
First eStandards conference Panel of the European SDO Platformchronaki
Introduction to panel where Standards Developing Organization and National Competence Centers discuss the scope of the European SDO platform reflecting on earlier presentations.
Healthcare: Leadership, Integration, Platforms; CCIO experiences in the NHSTony Shannon
Presentation to HISI 2015 on experiences as a CCIO.
Issues covered:
Healthcare under pressure
Need for medical leadership
Integration of care around the patient
Advent of open platform in healthcare
Changes ahead. Progress optional
Emergency Medicine Leaders: Technology for Quality & Performance: What Leader...Tony Shannon
Brief: Technological Solutions to Achieving Quality & Performance: What Leaders Need to Know
Exploration of;
Healthcare under Pressure
Need to work Smarter>Harder
Role of Medical Leadership (eg CCIO)
Complex Systems (eg EM) .. look for patterns
People Process + Tech = key Change Pattern
State of Healthcare IT market
EDIS improvement/procurement options
Case for open platform in Health IT and EM
Medical Leadership: Complex Systems: Open PlatformsTony Shannon
Workshop at the RCPI St Lukes Symposium on themes of;
21st Century Healthcare
Need for Medical Leadership
The Challenge of Complex Systems
The Promise of Open Platforms
Medical Leadership/Complex Systems/Open Data- Presentation Nov 2014Tony Shannon
Presentation to University College Dublin/Ireland East Hospital Group
Workshop: Contemporary Issues in Hospital Practice
Date: 2014 Nov 6th
Title: Medical Leadership/ Complex Systems/ Open Data
Connecting Leeds: Care Record: update ; EHILive 2014 presentationTony Shannon
Presentation of the EHILive 2014 CCIO conference.
Exploring within the Leeds NHS
History : PPM+ platform
Current: Leeds Care Record
Future: Integration Pioneers work
CILIP Cymru Wales Conference 2019: Mobilisation & Swansea Bay UHB Libraries CILIP
Rhys Whelan's presentation
Improving health literacy levels can enhance treatment outcomes, save time and cut costs. At NELFT, we are undertaking a pilot project to improve the health literacy of staff, patients and the wider communities we serve. We have partnered with local libraries and the Reading Agency to run high-street health information drop-ins. These events raise awareness of the evidence-based Reading Well book collections and signpost members of the public to accessible, peer-reviewed digital resources like the NHS app and the NHS ‘Behind the Headlines’ health news analysis. Future aims of the project include a health literacy e-learning module and reflective workshops.
Presentation by Dr Adrian Burton, ARDC, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
ONC Market R&D Pilot challenge Webinar finalhealth2dev
The Market R&D Pilot Challenge, brought to you by the Office of the National Coordinator for Health Information Technology (ONC), will help bridge technological gaps by bringing together health care organizations and innovative companies through $300,000 in pilot funding awards and facilitated matchmaking. This webinar provides more detail on the challenge and answers some common questions
A presentation by Jimmy Whitworth as part of the Sustainability and Ownership panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014
EU Clinical Trials Regulation - IPPOSI perspectiveipposi
IPPOSI CEO, Dr Derick Mitchell delivered a presentation on the EU Clinical Trials Regulation from the patients' perspective at the 20th International Conference on Pharmaceutical Medicine, Athens, Greece.
Medical Leadership/Complex Systems/Open Data- Presentation Nov 2014Tony Shannon
Presentation to University College Dublin/Ireland East Hospital Group
Workshop: Contemporary Issues in Hospital Practice
Date: 2014 Nov 6th
Title: Medical Leadership/ Complex Systems/ Open Data
Connecting Leeds: Care Record: update ; EHILive 2014 presentationTony Shannon
Presentation of the EHILive 2014 CCIO conference.
Exploring within the Leeds NHS
History : PPM+ platform
Current: Leeds Care Record
Future: Integration Pioneers work
CILIP Cymru Wales Conference 2019: Mobilisation & Swansea Bay UHB Libraries CILIP
Rhys Whelan's presentation
Improving health literacy levels can enhance treatment outcomes, save time and cut costs. At NELFT, we are undertaking a pilot project to improve the health literacy of staff, patients and the wider communities we serve. We have partnered with local libraries and the Reading Agency to run high-street health information drop-ins. These events raise awareness of the evidence-based Reading Well book collections and signpost members of the public to accessible, peer-reviewed digital resources like the NHS app and the NHS ‘Behind the Headlines’ health news analysis. Future aims of the project include a health literacy e-learning module and reflective workshops.
Presentation by Dr Adrian Burton, ARDC, to the 'Unlocking value from publicly funded Clinical Research Data' workshop, cohosted by ARDC and CSIRO at ANU on 6 March 2019.
ONC Market R&D Pilot challenge Webinar finalhealth2dev
The Market R&D Pilot Challenge, brought to you by the Office of the National Coordinator for Health Information Technology (ONC), will help bridge technological gaps by bringing together health care organizations and innovative companies through $300,000 in pilot funding awards and facilitated matchmaking. This webinar provides more detail on the challenge and answers some common questions
A presentation by Jimmy Whitworth as part of the Sustainability and Ownership panel discussion at the International Symposium on Cohort and Longitudinal Studies in Developing Contexts, UNICEF Office of Research - Innocenti, Florence, Italy 13-15 October 2014
EU Clinical Trials Regulation - IPPOSI perspectiveipposi
IPPOSI CEO, Dr Derick Mitchell delivered a presentation on the EU Clinical Trials Regulation from the patients' perspective at the 20th International Conference on Pharmaceutical Medicine, Athens, Greece.
5th Annual Early Age Onset Colorectal Cancer Summit - Session II: Family History Ascertainment in the US - What Steps are Needed to Improve the Well Documented Less Than Optimal Status of this Situation?
Anne Powell and Ruth Bottomley from INASP discuss INASP’s role in access to, production and use of research information.
Access: Why access is important, what INASP does, what publishers do/can do
Production: Research writing and local publishing support for Southern journals
Use: Taking research to policy and practice
Tom Mowlam from Ubiquity Press outlines Ubiquity’s work with Southern journals.
Finally, Neil Pakenham-Walsh, the Coordinator of HIFA (Healthcare Information For All) discusses access to and production of healthcare information specifically and the use of health research and journals by frontline workers.
Overview of Lodestone Logic services including business intelligence, strategic planning, and project execution. This presentation also includes a summary of Lodestone Logic's media channels and web presence.
Similar to Id 105 tt_nationwideremoteaccess[1] (20)
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
1. Leela Sawh-Phekoo, Librarian III, Ministry of Health
Sherma Peters, Business Systems Project Manager,
Ministry of Health
Ernesta Greenidge, Head, Medical Sciences Library,
University of the West Indies, St Augustine Campus
1
2. •
Aligned with one of Government’s pillars for Sustainable
Development
•
Readily available Government’s Information and
Communication Infrastructure which :•
•
•
supports effective communication/information
access locally and globally
supports ICT integration throughout the health sector
empowers its Medical Library Services network
2
3. Availability of up-to-date clinical information nationwide:
•
•
•
•
for the treatment of patients at point of care
for all health care professionals of Trinidad and Tobago
The promotion of research and development within the
health sector
3
4. • Project Team formation
• Defining the product
• Visit and assess similar libraries’ facility
• Discussions with service providers
• Determine prospective alliances
• Define the attributes of the product
• Present the product to the Ministry’s Administration
• Gain approval for product development
4
5. Nationwide Remote Access
The METHODOLOGY (cont’d)
• Execute Stakeholder Awareness Campaigns
(with medical practitioners - public & private sectors)
• Develop and streamline the product (pilot)
• Execute product training
• National launch of product (pilot) and press release
• Define Usage statistics and manage usage levels
5
6. Nationwide Remote Access
The PRODUCT
• A web-based facility which:
• is powered by EBSCOHost - our partner
• is accessible to all healthcare professionals in Trinidad &
Tobago
• provides leading medical databases which cover
areas such as research, therapy, rehabilitation
• can be accessed anywhere remotely via mobiles and PCs
• would require unique User Identification (after the pilot)
6
7. Nationwide Remote Access
The LAUNCH
From left: Mr O’Brian-MOH,
Mrs Antonia Popplewell-Permanent Secretary -MOH,
C. Kirton- MOH
The Medical Library Network Team with EBSCO personnel
The Minister’s speech at Launch http://youtu.be/LmllOXPiHR8
7
9. Challenges:
•
Inadequate operations staff
•
Uneven distribution of IT infrastructure
across the system
•
Increasing the involvement of key stakeholders at this
early stage
•
Non-availability of a Medical Library website
9
10. Nationwide Remote Access
Discussion (cont’d)
Opportunities:
• Subsequent creation of a Medical Library website
• The development of an application that would
provide secure access-control to these databases
• Resource sharing potential of consortia because of
the expensive nature of quality health information
resources
10
11. Way Forward:
• Increase awareness of and build commitment to this
initiative
•
Utilize the Virtual Health Library
as a space to promote the use of consumer health
information and as a reservoir of pertinent evidencebased health & medical resources to support projects such
as EVIPNET(a PAHO Project)
11
